Brain Tumor Reports
54

Volume 15 Number 10
October 2013


Home > Publications > Brain Tumor Reports > Volume 15 Year 2013 > Number 10, October*


CONTENTS



BRAIN TUMORS
GLIOBLASTOMA
GLIOMAS





BRAIN TUMORS



Gehrke AK, Baisley MC, Sonck AL, Wronski SL, Feuerstein M.
Neurocognitive deficits following primary brain tumor treatment: systematic review of a decade of comparative studies.
J Neurooncol. 2013 Aug 23. doi:10.1007/s11060-013-1215-2 .[Epub ahead of print]
Source | Abstract | Full text | Similar articles




Strodtbeck K, Sloan A, Rogers L, Fisher PG, Stearns D, Campbell L, Barnholtz-Sloan J.
Risk of subsequent cancer following a primary CNS tumor.
J Neurooncol. 2013 Apr;112(2):285-95. doi: 10.1007/s11060-013-1063-0. Epub 2013 Feb 8.
Source | Abstract | Full text | Similar articles





GLIOBLASTOMA



Alotaibi FE, Petrecca K.
Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide.
Case Rep Med. 2013;2013:591272. doi: 10.1155/2013/591272. Epub 2013 Aug 29.
Source | Abstract | Full text | Similar articles




Altaner C, Altanerova V, Cihova M, Ondicova K, Rychly B, Baciak L, Mravec B.
Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario.
Int J Cancer. 2013 Aug 26. doi: 10.1002/ijc.28455. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Chamberlain MC, Chi AS.
Is There a Role for Bevacizumab in the Treatment of Glioblastoma?
Oncologist. 2013 Sep 20. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Chaumeil MM, Larson PE, Yoshihara HA, Danforth OM, Vigneron DB, Nelson SJ, Pieper RO, Phillips JJ, Ronen SM
Non-invasive in vivo assessment of IDH1 mutational status in glioma.
Nat Commun. 2013 Sep 10;4:2429. doi: 10.1038/ncomms3429.
Source | Abstract | Full text | Similar articles




Ciammella P, Podgornii A, Galeandro M, D Abbiero N, Pisanello A, Botti A, Cagni E, Iori M, Iotti C.
Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience.
Radiat Oncol. 2013 Sep 25;8(1):222. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Costa B, Bendinelli S, Gabelloni P, Da Pozzo E, Daniele S, Scatena F, Vanacore R, Campiglia P, Bertamino A, Gomez-Monterrey I, Sorriento D, Del Giudice C, Iaccarino G, Novellino E, Martini C.
Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor.
PLoS One. 2013 Aug 19;8(8):e72281. doi: 10.1371/journal.pone.0072281.
Source | Abstract | Full text | Similar articles




Cuppini L, Calleri A, Bruzzone MG, Prodi E, Anghileri E, Pellegatta S, Mancuso P, Porrati P, Di Stefano AL, Ceroni M, Bertolini F, Finocchiaro G, Eoli M.
Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan.
PLoS One. 2013 Sep 12;8(9):e74345. doi: 10.1371/journal.pone.0074345.
Source | Abstract | Full text | Similar articles




De Felice F, Bulzonetti N, Musio D, D'Elia A, Salvati M, Tombolini V.
Low-dose Fotemustine as Second-line Chemotherapy for Recurrent Glioblastoma Multiforme.
Anticancer Res. 2013 Sep;33(9):4013-6.
Source | Abstract | Full text | Similar articles




Dubrow R, Darefsky AS, Jacobs DI, Park LS, Rose MG, Laurans MS, King JT Jr.
Time trends in glioblastoma multiforme survival: the role of temozolomide.
Neuro Oncol. 2013 Sep 17.
doi:10.1093/neuonc/not122[Epub ahead of print]
Source | Abstract | Full text | Similar articles




Han Z, DU Y, Qi H, Yin W.
Post-traumatic malignant glioma in a pregnant woman: case report and review of the literature.
Neurol Med Chir (Tokyo). 2013;53(9):630-4.
Source | Abstract | Full text | Similar articles




Hodges TR, Choi BD, Bigner DD, Yan H, Sampson JH.
Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review.
J Neurosurg. 2013 Jun;118(6):1176-80. doi: 10.3171/2013.3.JNS122282. Epub 2013 Apr 12.
Source | Abstract | Full text | Similar articles




Linhares P, Carvalho B, Figueiredo R, Reis RM, Vaz R.
Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation.
J Oncol. 2013;2013:690585. doi: 10.1155/2013/690585. Epub 2013 Aug 13.
Source | Abstract | Full text | Similar articles




Sarkar S, Rajaratnam S, Backianathan S, Chacko G, Chacko AG.
Radiation-induced opticochiasmatic glioblastoma multiforme following conventional radiotherapy for Cushing's disease.
Br J Neurosurg. 2013 Sep 25. http://dx.doi.org/10.3109/02688697.2013.841850. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Sawlani V, Taylor R, Rowley K, Redfern R, Martin J, Poptani H.
Magnetic Resonance Spectroscopy for Differentiating Pseudo-Progression from True Progression in GBM on Concurrent Chemoradiotherapy.
Neuroradiol J. 2012 Nov;25(5):575-86. Epub 2012 Nov 9.
Source | Abstract | Full text | Similar articles




Schonberg DL, Bao S, Rich JN.
Genomics informs glioblastoma biology.
Nat Genet. 2013 Sep 26;45(10):1105-7. doi: 10.1038/ng.2775.
Source | Abstract | Full text | Similar articles




Shankar A, Kumar S, Iskander A, Varma NR, Janic B, Decarvalho A, Mikkelsen T, Frank JA, Ali MM, Knight RA, Brown S, Arbab AS.
Subcurative radiation significantly increases proliferation, invasion, and migration of primary GBM in vivo.
Chin J Cancer. 2013 Sep 9. doi: 10.5732/cjc.013.10095. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Schaub C, Greschus S, Seifert M, Waha A, Blasius E, Rasch K, Landwehr C, Mack F, Schäfer N, Stuplich M, Kebir S, Vilz B, Scheffler B, Boström J, Simon M, Urbach H, Glas M, Herrlinger U.
FLAIR-Only Progression in Bevacizumab-Treated Relapsing Glioblastoma Does Not Predict Short Survival.
Oncology. 2013 Sep 5;85(3):191-195. https://doi.org/10.1159/000354692. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Söderberg-Nauclér C, Rahbar A, Stragliotto G.
Survival in patients with glioblastoma receiving valganciclovir.
N Engl J Med. 2013 Sep 5;369(10):985-6. doi: 10.1056/NEJMc1302145.
Source | Abstract | Full text | Similar articles




Vasco C, Canazza A, Rizzo A, Mossa A, Corsini E, Silvani A, Fariselli L, Salmaggi A, Ciusani E.
Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study.
J Neurooncol. 2013 Sep 5. doi:10.1007/s11060-013-1236-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Walker GV, Gilbert MR, Prabhu SS, Brown PD, McAleer MF.
Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice.
J Neurooncol. 2013 Mar;112(1):83-9. doi: 10.1007/s11060-012-1029-7. Epub 2012 Dec 25.
Source | Abstract | Full text | Similar articles




Zairi F, Aboukais R, Maurage CA, Assaker R.
Glioblastoma occurring after the surgical resection of a craniopharyngioma.
Br J Neurosurg. 2013 Sep 6. http://dx.doi.org/10.3109/02688697.2013.835381. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Zhao C, Zhang Y, Wang J.
A Meta-Analysis on the Diagnostic Performance of 18F-FDG and 11C-Methionine PET for Differentiating Brain Tumors.
AJNR Am J Neuroradiol. 2013 Sep 12. DOI: https://doi.org/10.3174/ajnr.A3718. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





GLIOMAS



Chen C, Huang R, Maclean A, Muzikansky A, Mukundan S, Wen PY, Norden AD.
Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival.
J Neurooncol. 2013 Aug 22. [Epub ahead of print]
Source |
Abstract | Full text | Similar articles




Strauss I, Jonas-Kimchi T, Bokstein F, Blumenthal D, Roth J, Sitt R, Wilson J, Ram Z.
Gliomas of the posterior fossa in adults.
J Neurooncol. 2013 Aug 27. [Epub ahead of print]
Source |
Abstract | Full text | Similar articles




Tamura K, Aoyagi M, Ando N, Ogishima T, Wakimoto H, Yamamoto M, Ohno K.
Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.
J Neurosurg. 2013 Aug 30. [Epub ahead of print]
Source |
Abstract | Full text | Similar articles




Zwinkels H, Dörr J, Kloet F, Taphoorn MJ, Vecht CJ.
Pregnancy in women with gliomas: a case-series and review of the literature.
J Neurooncol. 2013 Aug 25. [Epub ahead of print]
Source |
Abstract | Full text | Similar articles




HIGH-GRADE GLIOMAS


Galldiks N, Berhorn T, Blau T, Dunkl V, Fink GR, Schroeter M.
"One week on-one week off": efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center.
J Neurooncol. 2013 Apr;112(2):209-15. doi: 10.1007/s11060-013-1048-z. Epub 2013 Jan 9.
Source |
Abstract | Full text | Similar articles




Lubelski D, Abdullah KG, Weil RJ, Marko NF.
Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
J Neurooncol. 2013 Sep 5. [Epub ahead of print]
Source |
Abstract | Full text | Similar articles




Macdonald TJ, Vezina G, Stewart CF, Turner D, Pierson CR, Chen L, Pollack IF, Gajjar A, Kieran MW.
Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: A report from the Children's Oncology Group.
Neuro Oncol. 2013 Oct;15(10):1438-44. doi: 10.1093/neuonc/not058. Epub 2013 Sep 5.
Source |
Abstract | Full text | Similar articles




Rodríguez-Hernández I, Garcia JL, Santos-Briz A, Hernández-Laín A, González-Valero JM, Gómez-Moreta JA, Toldos-González O, Cruz JJ, Martin-Vallejo J, González-Sarmiento R.
Integrated analysis of mismatch repair system in malignant astrocytomas.
PLoS One. 2013 Sep 20;8(9):e76401. doi: 10.1371/journal.pone.0076401.
Source |
Abstract | Full text | Similar articles




Wick W, Meisner C, Hentschel B, Platten M, Schilling A, Wiestler B, Sabel MC, Koeppen S, Ketter R, Weiler M, Tabatabai G, von Deimling A, Gramatzki D, Westphal M, Schackert G, Loeffler M, Simon M, Reifenberger G, Weller M.
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.
Neurology. 2013 Sep 25. [Epub ahead of print]
Source |
Abstract | Full text | Similar articles